Pulse Biosciences, Inc. PLSE Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulse Biosciences, Inc.'s cash provided by (used in) financing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulse Biosciences, Inc.'s cash provided by (used in) financing activity, including discontinued operation?
- Pulse Biosciences, Inc. (PLSE) reported cash provided by (used in) financing activity, including discontinued operation of $2.21M in Q1 2026.
- How has Pulse Biosciences, Inc.'s cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
- Pulse Biosciences, Inc.'s cash provided by (used in) financing activity, including discontinued operation decreased by 85.1% year-over-year, from $14.81M to $2.21M.
- What is the long-term trend for Pulse Biosciences, Inc.'s cash provided by (used in) financing activity, including discontinued operation?
- Over 4 years (2021 to 2025), Pulse Biosciences, Inc.'s cash provided by (used in) financing activity, including discontinued operation has grown at a -27.8% compound annual growth rate (CAGR), from $63.23M to $17.15M.
- What does cash provided by (used in) financing activity, including discontinued operation mean?
- This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.